ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Session » Sjögren's Syndrome - Clinical

Meeting: 2012 ACR/ARHP Annual Meeting

Abstract Number: 2174
Natural History of Sjögren’s Syndrome Phenotypic Features in the Sjögren’s International Collaborative Clinical Alliance Registry
Abstract Number: 2175
Interstitial Lung Disease in Sjogren Syndrome: A Population-Based Study
Abstract Number: 2176
Pulmonary Manifestations and Treatment of Primary Sjogren’s Syndrome-Associated Lung Involvement Patients: A Prospective Study
Abstract Number: 2177
The Forced Oscillation Technique Is a Sensitive Method for Detection of Obstructive Airway Disease in Patients with Primary Sjögren’s Syndrome
Abstract Number: 2178
18-Fludeoxyglucose Positron Emission Tomography Is a Valuable Marker of Activity of Interstitial Lung Disease in Primary Sjogren’s Syndrome
Abstract Number: 2179
High Resolution CT Findings and Concomitant Nontuberculosis Mycobacterial Infection (NTM) in Patients with the Diagnosis of Primary Sjogren’s Syndrome Evaluated At a Respiratory Referral Center
Abstract Number: 2180
Coronary Flow Reserve and Asymmetric Dimethylarginine Levels: New Measurements for Identifying Subclinical Atherosclerosis in Patients with Primary Sjögren’s Syndrome
Abstract Number: 2181
Concomitant Atheosclerosis and Impaired Bone Health in Patients with Primary Sjogren’s Syndrome
Abstract Number: 2182
Prevalence of Fibromyalgia Is Increased in Primary Sjögren’s Syndrome Compared with SLE and Associated with Depression and Severe Vitamin D Deficiency
Abstract Number: 2183
Common Features in Lymphoproliferative Complications in the Course of Primary Sjögren’s Syndrome: Results From a Multicenter Cohort of 1170 Patients
Abstract Number: 2184
Pregnancy and Fetal Outcome in Patients with an Established Diagnosis of Primary Sjögren’s Syndrome.
Abstract Number: 2185
Prevalence of Severe Extra-Glandular Manifestations in a Large Cohort of Patients with Primary Sjögren’s Syndrome
Abstract Number: 2186
Ultrasonography of Major Salivary Glands in Primary Sjögren’s syndrome
Abstract Number: 2187
Safety of Minor Labial Salivary Gland Biopsy
Abstract Number: 2188
How to Better Define Inclusion Criteria in a Large Controlled Trial in Primary Sjogren Syndrome ?
Abstract Number: 2189
Efficacy of Belimumab On Non-Malignant Parotid Swelling and Systemic Manifestations of Sjögren’s Syndrome: Results of the Beliss Study
Abstract Number: 2190
Antimalarials for Sjogren’s Syndrome Treatment in Adults, Meta-Analysis
Abstract Number: 2191
Secretagogue Use in Patients with Primary Sjogren’s Syndrome
Abstract Number: 2192
Phenotypic Features of Sjögren’s Syndrome Among Patients with Low-Titer SSA/B Antibodies
Abstract Number: 2193
Validity of Low Titers of SSA/B Antibodies in Predicting A Key Feature of Sjögren’s Syndrome
Abstract Number: 2194
Cathepsin S Activity in Tears As a Marker of Sjögren’s Syndrome
Abstract Number: 2195
Long-Term Changes in Autoantibody Profile After Pandemic Unadjuvanted Influenza A/H1N1 Vaccine in Sjögren’s Syndrome
Abstract Number: 2196
Decreased Expression of TSLP in Labial Salivary Glands of Patients with pSS Is Associated with Local and Systemic Disease Parameters
Abstract Number: 2197
Diagnostic Value of Blood B-Cell Subset Profiling and Autoimmunity Markers in Anti-SSA-Negative Sjögren’s Syndrome Patients
Abstract Number: 2198
Interstitial Lung Disease in Primary Sjogren’s Syndrome: Any Association with IgG4 Related Sclerosing Disease?
Abstract Number: 2199
Elevated IgG4 Serum Levels Among Primary Sjogren’s Syndrome Patients: Do They Unmask Underlying IgG4-Related Disease?
Abstract Number: 2200
IgE Autoantibodies Against SSA and SSB in Patients with Sjögren’s Syndrome and Healthy Controls
Abstract Number: 2201
Involvement of Interleukin-33 in the Pathogenesis of Sjögren’s Syndrome
Abstract Number: 2202
Classification Criteria for Sjögren’s Syndrome: Comparison of the Performance of the 2002 American-European Consensus Group Criteria (AECG) and the 2012 ACR Criteria
Abstract Number: 2203
Effects of Reclassification Using the American College of Rheumatology Criteria On a Large cohort Sjögren’s Syndrome Patients
Abstract Number: 2204
Overall Agreement Between Sjögrens’s Minor Salivary Gland Biopsy and 2002 and 2012 Classification Criteria
Abstract Number: 2205
Longitudinal Evaluation of the Performance of Different Classification Criteria in Patients with Primary Sjögren’s Syndrome

« View all sessions from this meeting

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2022 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies